NMPA to Deepen the Reform of Cosmetics Regulation

The National Medical Products Administration (NMPA) recently drafted the Opinions on Deepening the Reform of Cosmetics Regulation and Promoting High-quality Industrial Development (Draft for Comment) (the "Draft") to solicit public opinions by October 10, 2025.

The Draft envisions that, by 2035, China's regulatory system for cosmetics quality and safety will reach an advanced level globally, with the regulatory framework, regulatory mechanisms, and regulatory approaches better aligned with the intrinsic requirements of industrial innovation and high-quality development, the relevant industry will have stronger innovative capacity and global competitiveness, and regulatory modernization essentially realized. To this end, the Draft identifies multiple major tasks such as increasing support for innovation in the cosmetics industry and enhancing the efficiency of cosmetics registration and filing management. Notably, the Draft calls for encouraging the launch of new cosmetics products in China. For innovative and pioneering international cosmetics products first launched in China, or launched simultaneously in China and other countries (regions), once the requirements for registration and filing materials under Chinese regulations are met, they will be deemed as cosmetics manufactured exclusively for export to China, and thus exempted from submitting the proof of having been marketed in the country (region) of manufacture.



(Source: https://www.nmpa.gov.cn/xxgk/zhqyj/zhqyjhzhp/20250919161434160.html)

Note: The link to the Chinese official website of the document is for your reference.